Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Green Med Solution (BGMS) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to $6000.0.

  • Bio Green Med Solution's Share-based Compensation fell 9439.25% to $6000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 11583.43%. This contributed to the annual value of $592000.0 for FY2024, which is 5980.99% down from last year.
  • Bio Green Med Solution's Share-based Compensation amounted to $6000.0 in Q3 2025, which was down 9439.25% from $7000.0 recorded in Q2 2025.
  • Bio Green Med Solution's Share-based Compensation's 5-year high stood at $1.7 million during Q1 2025, with a 5-year trough of $6000.0 in Q3 2025.
  • Moreover, its 5-year median value for Share-based Compensation was $319000.0 (2021), whereas its average is $337105.3.
  • Data for Bio Green Med Solution's Share-based Compensation shows a peak YoY increase of 72068.97% (in 2025) and a maximum YoY decrease of 9629.63% (in 2025) over the last 5 years.
  • Bio Green Med Solution's Share-based Compensation (Quarter) stood at $304000.0 in 2021, then increased by 27.3% to $387000.0 in 2022, then fell by 16.8% to $322000.0 in 2023, then crashed by 71.12% to $93000.0 in 2024, then plummeted by 93.55% to $6000.0 in 2025.
  • Its Share-based Compensation stands at $6000.0 for Q3 2025, versus $7000.0 for Q2 2025 and $1.7 million for Q1 2025.